NCT02568397 A Drug-drug Interaction Study of Lanabecestat (LY3314814) in Healthy Participants Status COMPLETED Phase PHASE1
NCT02564900 Study of DS-8201a in Subjects With Advanced Solid Malignant Tumors Status COMPLETED Phase PHASE1
NCT02561845 Effectiveness of Statins on Lipid Goal Attainment and Lipid Parameters in PCI Patients Status WITHDRAWN Phase N/A
NCT02561832 A Phase I, Open-Label, 2 Part Multicentre Study to Assess the Safety and Efficacy of Olaparib in Combination With Carboplatin in Patients With Advanced HER-2 Negative Breast Cancer Status TERMINATED Phase PHASE1
NCT02561130 Remission Evaluation of a Metabolic Intervention in Type 2 Diabetes With Forxiga Status COMPLETED Phase PHASE4
NCT02560363 A Study to Compare the Pharmacokinetics of Different Formulations of AZD9977 and the Influence of Food in Healthy Male Subjects Status WITHDRAWN Phase PHASE1
NCT02558894 Phase II Study of MEDI4736 Monotherapy or in Combinations With Tremelimumab in Metastatic Pancreatic Ductal Carcinoma Status COMPLETED Phase PHASE2
NCT02552160 DETECT-Register DocumEnTation and Evaluation of a COPD Combination Therapy Status COMPLETED Phase N/A
NCT02551874 A 24-week Open-Label, Phase 3b Trial With a 28-week Extension to Evaluate the Efficacy and Safety of Saxagliptin Co-administered With Dapagliflozin Compared to Insulin Glargine in Subjects withType 2 Diabetes Who Have Glycemic Control on Metformin Status COMPLETED Phase PHASE3
NCT02551159 Phase III Open Label Study of MEDI 4736 With/Without Tremelimumab Versus Standard of Care (SOC) in Recurrent/Metastatic Head and Neck Cancer Status COMPLETED Phase PHASE3
NCT02547935 A Study to Evaluate the Effect of Dapagliflozin With and Without Saxagliptin on Albuminuria, and to Investigate the Effect of Dapagliflozin and Saxagliptin on HbA1c in Patients With Type 2 Diabetes and CKD Status COMPLETED Phase PHASE2/PHASE3
NCT02547922 Safety and Efficacy of Two Doses of Anifrolumab Compared to Placebo in Adult Subjects With Active Proliferative Lupus Nephritis Status COMPLETED Phase PHASE2
NCT02546661 Open-Label, Randomised, Multi-Drug, Biomarker-Directed, Phase 1b Study in Pts w/ Muscle Invasive Bladder Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT02546323 A phase3 Study Measuring the Effect of Rosuvastatin 20 mg on Carotid Intima-Media Thickness in Chinese Subjects With Subclinical Atherosclerosis Status COMPLETED Phase PHASE3
NCT02543476 SUPREME-HN A Retrospective Cohort Study of PD-L1 in Recurrent and Metastatic Squamous Cell Carcinoma of Head and Neck (SCCHN) Status COMPLETED Phase N/A
NCT02542293 Study of Durvalumab With Tremelimumab Versus SoC as 1st Line Therapy in Metastatic Non Small-Cell Lung Cancer (NSCLC) (NEPTUNE) Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT02540668 A Drug Interaction Study of Lanabecestat (LY3314814) and Warfarin in Healthy Participants Status COMPLETED Phase PHASE1
NCT02537418 Durvalumab With or Without Tremelimumab in Advanced Incurable Solid Malignancies Given With or Without Standard Chemotherapy Regimens Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT02535078 Phase 1b/2 Study of the Combination of IMCgp100 With Durvalumab and/or Tremelimumab in Advanced Cutaneous Melanoma Status WITHDRAWN Phase PHASE1/PHASE2